VitaSpring Biomedical Balance Sheet

Financials in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Cash & Equivalents	0	0	0.03	0.11	0.05
Short-Term Investments	-	0.02	-	-	-
Cash & Short-Term Investments	0	0.02	0.03	0.11	0.05
Cash Growth	-98.85%	-20.33%	-72.34%	136.16%	-
Receivables	-	-	0.38	2.95	-
Inventory	-	-	-	-	0.14
Prepaid Expenses	-	-	0.03	0	-
Total Current Assets	0	0.02	0.44	3.06	0.19
Property, Plant & Equipment	0.01	0.11	0.31	0.52	-
Other Long-Term Assets	-	-	0.02	0.02	-
Total Assets	0.01	0.14	0.77	3.6	0.19
Accounts Payable	2.91	2.75	2.47	1.25	-
Current Portion of Leases	-	0.09	0.17	0.18	-
Current Income Taxes Payable	0.31	0.22	0.22	0.21	-
Other Current Liabilities	0.81	0.43	0.21	0.09	0.09
Total Current Liabilities	4.03	3.49	3.07	1.74	0.09
Long-Term Leases	-	-	0.09	0.28	-
Long-Term Deferred Tax Liabilities	-	-	-	0.01	-
Total Liabilities	4.03	3.49	3.16	2.03	0.09
Common Stock	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	1.25	1.14	0.97	0.78	0.81
Retained Earnings	-5.28	-4.51	-3.39	0.78	-0.45
Comprehensive Income & Other	-	-	-	-	-0.29
Shareholders' Equity	-4.02	-3.35	-2.4	1.58	0.1
Total Liabilities & Equity	0.01	0.14	0.77	3.6	0.19
Total Debt	-	0.09	0.26	0.46	-
Net Cash (Debt)	0	-0.07	-0.23	-0.36	0.05
Net Cash Per Share	-	-0.00	-0.00	-0.00	0.00
Filing Date Shares Outstanding	207.03	207.03	207.03	206.52	209.67
Total Common Shares Outstanding	207.03	207.03	207.03	206.52	209.67
Working Capital	-4.03	-3.46	-2.63	1.32	0.1
Book Value Per Share	-0.02	-0.02	-0.01	0.01	0.00
Tangible Book Value	-4.02	-3.35	-2.4	1.58	0.1
Tangible Book Value Per Share	-0.02	-0.02	-0.01	0.01	0.00
Machinery	0.06	0.06	0.07	0.07	-